nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—SGCD—dilated cardiomyopathy	0.0474	0.12	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—SGCD—dilated cardiomyopathy	0.0264	0.067	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—DSG2—dilated cardiomyopathy	0.0249	0.0631	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—DES—dilated cardiomyopathy	0.0189	0.0478	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—EMD—dilated cardiomyopathy	0.0176	0.0445	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—RYR2—dilated cardiomyopathy	0.0165	0.0418	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.0149	0.0378	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.0143	0.0363	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—DSG2—dilated cardiomyopathy	0.0139	0.0352	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.0125	0.0317	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—DES—dilated cardiomyopathy	0.0105	0.0267	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—EMD—dilated cardiomyopathy	0.00979	0.0248	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—RYR2—dilated cardiomyopathy	0.0092	0.0233	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00857	0.0217	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.00832	0.0211	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.00798	0.0202	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00793	0.0201	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00772	0.0196	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.00697	0.0177	CbGpPWpGaD
Gabapentin—CACNA2D1—cardiac ventricle—dilated cardiomyopathy	0.00686	0.136	CbGeAlD
Gabapentin—BCAT1—heart—dilated cardiomyopathy	0.00682	0.135	CbGeAlD
Gabapentin—CACNA2D1—myocardium—dilated cardiomyopathy	0.00645	0.128	CbGeAlD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.00644	0.0163	CbGpPWpGaD
Gabapentin—CACNA2D2—heart—dilated cardiomyopathy	0.00626	0.124	CbGeAlD
Gabapentin—ADORA1—myocardium—dilated cardiomyopathy	0.00622	0.123	CbGeAlD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.00611	0.0155	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00544	0.0138	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00544	0.0138	CbGpPWpGaD
Gabapentin—CACNA2D2—cardiac atrium—dilated cardiomyopathy	0.00535	0.106	CbGeAlD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00478	0.0121	CbGpPWpGaD
Gabapentin—CACNA2D1—heart—dilated cardiomyopathy	0.0045	0.0891	CbGeAlD
Gabapentin—CACNA1B—Neuronal System—ABCC9—dilated cardiomyopathy	0.00434	0.011	CbGpPWpGaD
Gabapentin—ADORA1—heart—dilated cardiomyopathy	0.00434	0.086	CbGeAlD
Gabapentin—CACNA1B—Neuronal System—ACTN2—dilated cardiomyopathy	0.00416	0.0106	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00375	0.00951	CbGpPWpGaD
Gabapentin—ADORA1—cardiac atrium—dilated cardiomyopathy	0.00371	0.0735	CbGeAlD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0036	0.00913	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.00359	0.0091	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.00341	0.00863	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.0031	0.00785	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00304	0.00771	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00301	0.00762	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00288	0.00729	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00276	0.00699	CbGpPWpGaD
Gabapentin—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00247	0.00446	CcSEcCtD
Gabapentin—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00246	0.00444	CcSEcCtD
Gabapentin—Viral infection—Lisinopril—dilated cardiomyopathy	0.00246	0.00444	CcSEcCtD
Gabapentin—Polyuria—Furosemide—dilated cardiomyopathy	0.00245	0.00442	CcSEcCtD
Gabapentin—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00245	0.00441	CcSEcCtD
Gabapentin—Swelling—Furosemide—dilated cardiomyopathy	0.00244	0.0044	CcSEcCtD
Gabapentin—Cough increased—Lisinopril—dilated cardiomyopathy	0.00243	0.00438	CcSEcCtD
Gabapentin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00242	0.00436	CcSEcCtD
Gabapentin—Deafness—Furosemide—dilated cardiomyopathy	0.00241	0.00433	CcSEcCtD
Gabapentin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00241	0.00433	CcSEcCtD
Gabapentin—Drug interaction—Lisinopril—dilated cardiomyopathy	0.0024	0.00432	CcSEcCtD
Gabapentin—Gout—Lisinopril—dilated cardiomyopathy	0.00238	0.00429	CcSEcCtD
Gabapentin—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00234	0.00421	CcSEcCtD
Gabapentin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00229	0.00413	CcSEcCtD
Gabapentin—Thirst—Furosemide—dilated cardiomyopathy	0.00226	0.00407	CcSEcCtD
Gabapentin—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00225	0.00406	CcSEcCtD
Gabapentin—Neck pain—Lisinopril—dilated cardiomyopathy	0.00225	0.00406	CcSEcCtD
Gabapentin—Purpura—Furosemide—dilated cardiomyopathy	0.00223	0.00402	CcSEcCtD
Gabapentin—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00222	0.00401	CcSEcCtD
Gabapentin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00221	0.00398	CcSEcCtD
Gabapentin—Lethargy—Furosemide—dilated cardiomyopathy	0.0022	0.00396	CcSEcCtD
Gabapentin—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00217	0.00391	CcSEcCtD
Gabapentin—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00216	0.00389	CcSEcCtD
Gabapentin—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00216	0.00389	CcSEcCtD
Gabapentin—Malaise—Spironolactone—dilated cardiomyopathy	0.00215	0.00387	CcSEcCtD
Gabapentin—Cystitis—Lisinopril—dilated cardiomyopathy	0.00215	0.00387	CcSEcCtD
Gabapentin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00213	0.00384	CcSEcCtD
Gabapentin—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00211	0.00381	CcSEcCtD
Gabapentin—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00209	0.00376	CcSEcCtD
Gabapentin—Photophobia—Lisinopril—dilated cardiomyopathy	0.00209	0.00376	CcSEcCtD
Gabapentin—Irritability—Furosemide—dilated cardiomyopathy	0.00205	0.0037	CcSEcCtD
Gabapentin—Urinary retention—Furosemide—dilated cardiomyopathy	0.00205	0.00369	CcSEcCtD
Gabapentin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00202	0.00363	CcSEcCtD
Gabapentin—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00201	0.00362	CcSEcCtD
Gabapentin—Discomfort—Spironolactone—dilated cardiomyopathy	0.002	0.00361	CcSEcCtD
Gabapentin—Dehydration—Furosemide—dilated cardiomyopathy	0.002	0.00361	CcSEcCtD
Gabapentin—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00198	0.00357	CcSEcCtD
Gabapentin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00196	0.00353	CcSEcCtD
Gabapentin—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00195	0.00351	CcSEcCtD
Gabapentin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00194	0.0035	CcSEcCtD
Gabapentin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0019	0.00343	CcSEcCtD
Gabapentin—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0019	0.00342	CcSEcCtD
Gabapentin—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00186	0.00334	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00186	0.0047	CbGpPWpGaD
Gabapentin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00185	0.00333	CcSEcCtD
Gabapentin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00184	0.00332	CcSEcCtD
Gabapentin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00182	0.00329	CcSEcCtD
Gabapentin—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00182	0.00328	CcSEcCtD
Gabapentin—Eczema—Lisinopril—dilated cardiomyopathy	0.0018	0.00324	CcSEcCtD
Gabapentin—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.0018	0.00324	CcSEcCtD
Gabapentin—Injury—Lisinopril—dilated cardiomyopathy	0.00176	0.00317	CcSEcCtD
Gabapentin—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00175	0.00315	CcSEcCtD
Gabapentin—BCAT1—Metabolism—TAZ—dilated cardiomyopathy	0.00175	0.00442	CbGpPWpGaD
Gabapentin—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00174	0.00314	CcSEcCtD
Gabapentin—Somnolence—Spironolactone—dilated cardiomyopathy	0.00173	0.00311	CcSEcCtD
Gabapentin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00172	0.0031	CcSEcCtD
Gabapentin—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.0017	0.00307	CcSEcCtD
Gabapentin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.0017	0.00306	CcSEcCtD
Gabapentin—Renal impairment—Lisinopril—dilated cardiomyopathy	0.0017	0.00306	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00168	0.00302	CcSEcCtD
Gabapentin—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00168	0.00302	CcSEcCtD
Gabapentin—Arthritis—Lisinopril—dilated cardiomyopathy	0.00166	0.00299	CcSEcCtD
Gabapentin—Drowsiness—Furosemide—dilated cardiomyopathy	0.00166	0.00299	CcSEcCtD
Gabapentin—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00165	0.00298	CcSEcCtD
Gabapentin—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00165	0.00297	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00164	0.00296	CcSEcCtD
Gabapentin—Renal failure—Furosemide—dilated cardiomyopathy	0.00163	0.00294	CcSEcCtD
Gabapentin—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00162	0.00292	CcSEcCtD
Gabapentin—Diplopia—Lisinopril—dilated cardiomyopathy	0.00161	0.00291	CcSEcCtD
Gabapentin—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00161	0.00291	CcSEcCtD
Gabapentin—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00161	0.00291	CcSEcCtD
Gabapentin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0016	0.00289	CcSEcCtD
Gabapentin—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.0016	0.00289	CcSEcCtD
Gabapentin—Sweating—Furosemide—dilated cardiomyopathy	0.00159	0.00286	CcSEcCtD
Gabapentin—BCAT1—Metabolism—SDHA—dilated cardiomyopathy	0.00158	0.004	CbGpPWpGaD
Gabapentin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00157	0.00283	CcSEcCtD
Gabapentin—Face oedema—Lisinopril—dilated cardiomyopathy	0.00156	0.00281	CcSEcCtD
Gabapentin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00154	0.00278	CcSEcCtD
Gabapentin—Irritability—Lisinopril—dilated cardiomyopathy	0.00154	0.00278	CcSEcCtD
Gabapentin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00154	0.00277	CcSEcCtD
Gabapentin—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00154	0.00277	CcSEcCtD
Gabapentin—Ataxia—Lisinopril—dilated cardiomyopathy	0.00152	0.00274	CcSEcCtD
Gabapentin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00151	0.00273	CcSEcCtD
Gabapentin—Dehydration—Lisinopril—dilated cardiomyopathy	0.0015	0.00271	CcSEcCtD
Gabapentin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00147	0.00265	CcSEcCtD
Gabapentin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00146	0.00263	CcSEcCtD
Gabapentin—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00146	0.00263	CcSEcCtD
Gabapentin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00144	0.0026	CcSEcCtD
Gabapentin—Visual impairment—Furosemide—dilated cardiomyopathy	0.00143	0.00259	CcSEcCtD
Gabapentin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00143	0.00258	CcSEcCtD
Gabapentin—Gastritis—Lisinopril—dilated cardiomyopathy	0.00143	0.00257	CcSEcCtD
Gabapentin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00141	0.00254	CcSEcCtD
Gabapentin—Influenza—Lisinopril—dilated cardiomyopathy	0.0014	0.00251	CcSEcCtD
Gabapentin—Asthma—Lisinopril—dilated cardiomyopathy	0.0014	0.00251	CcSEcCtD
Gabapentin—Eye disorder—Furosemide—dilated cardiomyopathy	0.00139	0.00251	CcSEcCtD
Gabapentin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00139	0.0025	CcSEcCtD
Gabapentin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00138	0.00249	CcSEcCtD
Gabapentin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00138	0.00248	CcSEcCtD
Gabapentin—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00137	0.00247	CcSEcCtD
Gabapentin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00137	0.00247	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00136	0.00345	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00136	0.00345	CbGpPWpGaD
Gabapentin—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00136	0.00245	CcSEcCtD
Gabapentin—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00136	0.00245	CcSEcCtD
Gabapentin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00134	0.00242	CcSEcCtD
Gabapentin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00134	0.00242	CcSEcCtD
Gabapentin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00133	0.0024	CcSEcCtD
Gabapentin—Dysuria—Lisinopril—dilated cardiomyopathy	0.0013	0.00235	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.0013	0.00234	CcSEcCtD
Gabapentin—Malnutrition—Furosemide—dilated cardiomyopathy	0.0013	0.00234	CcSEcCtD
Gabapentin—Erythema—Furosemide—dilated cardiomyopathy	0.0013	0.00234	CcSEcCtD
Gabapentin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00129	0.00232	CcSEcCtD
Gabapentin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00129	0.00232	CcSEcCtD
Gabapentin—Flatulence—Furosemide—dilated cardiomyopathy	0.00128	0.0023	CcSEcCtD
Gabapentin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00127	0.0023	CcSEcCtD
Gabapentin—Weight increased—Lisinopril—dilated cardiomyopathy	0.00127	0.00229	CcSEcCtD
Gabapentin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00127	0.00229	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00127	0.00321	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00126	0.0032	CbGpPWpGaD
Gabapentin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00126	0.00227	CcSEcCtD
Gabapentin—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00126	0.00227	CcSEcCtD
Gabapentin—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00125	0.00226	CcSEcCtD
Gabapentin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00125	0.00225	CcSEcCtD
Gabapentin—Depression—Lisinopril—dilated cardiomyopathy	0.00124	0.00224	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00124	0.00313	CbGpPWpGaD
Gabapentin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00124	0.00223	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00123	0.00222	CcSEcCtD
Gabapentin—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00123	0.00221	CcSEcCtD
Gabapentin—Rash—Spironolactone—dilated cardiomyopathy	0.00123	0.00221	CcSEcCtD
Gabapentin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00122	0.00221	CcSEcCtD
Gabapentin—Renal failure—Lisinopril—dilated cardiomyopathy	0.00122	0.0022	CcSEcCtD
Gabapentin—Vision blurred—Furosemide—dilated cardiomyopathy	0.00122	0.0022	CcSEcCtD
Gabapentin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00122	0.0022	CcSEcCtD
Gabapentin—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00122	0.0022	CcSEcCtD
Gabapentin—Headache—Spironolactone—dilated cardiomyopathy	0.00122	0.00219	CcSEcCtD
Gabapentin—Jaundice—Lisinopril—dilated cardiomyopathy	0.00121	0.00219	CcSEcCtD
Gabapentin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00121	0.00218	CcSEcCtD
Gabapentin—Anaemia—Furosemide—dilated cardiomyopathy	0.0012	0.00216	CcSEcCtD
Gabapentin—Sweating—Lisinopril—dilated cardiomyopathy	0.00119	0.00215	CcSEcCtD
Gabapentin—Agitation—Furosemide—dilated cardiomyopathy	0.00119	0.00215	CcSEcCtD
Gabapentin—Haematuria—Lisinopril—dilated cardiomyopathy	0.00119	0.00214	CcSEcCtD
Gabapentin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00118	0.00212	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00117	0.00298	CbGpPWpGaD
Gabapentin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00117	0.00211	CcSEcCtD
Gabapentin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00117	0.0021	CcSEcCtD
Gabapentin—Vertigo—Furosemide—dilated cardiomyopathy	0.00116	0.0021	CcSEcCtD
Gabapentin—Leukopenia—Furosemide—dilated cardiomyopathy	0.00116	0.00209	CcSEcCtD
Gabapentin—Nausea—Spironolactone—dilated cardiomyopathy	0.00115	0.00208	CcSEcCtD
Gabapentin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00114	0.00205	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00114	0.00288	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00112	0.00285	CbGpPWpGaD
Gabapentin—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00112	0.00202	CcSEcCtD
Gabapentin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00112	0.00201	CcSEcCtD
Gabapentin—Hallucination—Lisinopril—dilated cardiomyopathy	0.00111	0.002	CcSEcCtD
Gabapentin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00111	0.002	CcSEcCtD
Gabapentin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.0011	0.00199	CcSEcCtD
Gabapentin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.0011	0.00198	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0011	0.00197	CcSEcCtD
Gabapentin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00109	0.00197	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00108	0.00274	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00108	0.00274	CbGpPWpGaD
Gabapentin—Dry mouth—Furosemide—dilated cardiomyopathy	0.00108	0.00194	CcSEcCtD
Gabapentin—Confusional state—Furosemide—dilated cardiomyopathy	0.00107	0.00192	CcSEcCtD
Gabapentin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00106	0.00191	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—TAZ—dilated cardiomyopathy	0.00106	0.00268	CbGpPWpGaD
Gabapentin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00106	0.0019	CcSEcCtD
Gabapentin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00104	0.00188	CcSEcCtD
Gabapentin—Shock—Furosemide—dilated cardiomyopathy	0.00104	0.00188	CcSEcCtD
Gabapentin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00104	0.00187	CcSEcCtD
Gabapentin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00104	0.00187	CcSEcCtD
Gabapentin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00103	0.00185	CcSEcCtD
Gabapentin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00102	0.00184	CcSEcCtD
Gabapentin—Anorexia—Furosemide—dilated cardiomyopathy	0.00101	0.00182	CcSEcCtD
Gabapentin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00101	0.00181	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00101	0.00255	CbGpPWpGaD
Gabapentin—Chills—Lisinopril—dilated cardiomyopathy	0.001	0.00181	CcSEcCtD
Gabapentin—Hypotension—Furosemide—dilated cardiomyopathy	0.000988	0.00178	CcSEcCtD
Gabapentin—Alopecia—Lisinopril—dilated cardiomyopathy	0.000987	0.00178	CcSEcCtD
Gabapentin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000979	0.00176	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000974	0.00247	CbGpPWpGaD
Gabapentin—Erythema—Lisinopril—dilated cardiomyopathy	0.000972	0.00175	CcSEcCtD
Gabapentin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000972	0.00175	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000971	0.00246	CbGpPWpGaD
Gabapentin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000958	0.00173	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SDHA—dilated cardiomyopathy	0.000956	0.00242	CbGpPWpGaD
Gabapentin—Tension—Lisinopril—dilated cardiomyopathy	0.000954	0.00172	CcSEcCtD
Gabapentin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000952	0.00172	CcSEcCtD
Gabapentin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00095	0.00171	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—RAF1—dilated cardiomyopathy	0.000948	0.0024	CbGpPWpGaD
Gabapentin—Nervousness—Lisinopril—dilated cardiomyopathy	0.000944	0.0017	CcSEcCtD
Gabapentin—Back pain—Lisinopril—dilated cardiomyopathy	0.000941	0.00169	CcSEcCtD
Gabapentin—Somnolence—Furosemide—dilated cardiomyopathy	0.00094	0.00169	CcSEcCtD
Gabapentin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000935	0.00168	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000921	0.00234	CbGpPWpGaD
Gabapentin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000919	0.00166	CcSEcCtD
Gabapentin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000916	0.00165	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000913	0.00165	CcSEcCtD
Gabapentin—Fatigue—Furosemide—dilated cardiomyopathy	0.000912	0.00164	CcSEcCtD
Gabapentin—Tremor—Lisinopril—dilated cardiomyopathy	0.000911	0.00164	CcSEcCtD
Gabapentin—Pain—Furosemide—dilated cardiomyopathy	0.000904	0.00163	CcSEcCtD
Gabapentin—Constipation—Furosemide—dilated cardiomyopathy	0.000904	0.00163	CcSEcCtD
Gabapentin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000902	0.00163	CcSEcCtD
Gabapentin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000899	0.00162	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000891	0.00226	CbGpPWpGaD
Gabapentin—Angioedema—Lisinopril—dilated cardiomyopathy	0.000888	0.0016	CcSEcCtD
Gabapentin—Malaise—Lisinopril—dilated cardiomyopathy	0.000877	0.00158	CcSEcCtD
Gabapentin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000874	0.00157	CcSEcCtD
Gabapentin—Syncope—Lisinopril—dilated cardiomyopathy	0.000872	0.00157	CcSEcCtD
Gabapentin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000872	0.00157	CcSEcCtD
Gabapentin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00087	0.00157	CcSEcCtD
Gabapentin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000865	0.00156	CcSEcCtD
Gabapentin—Palpitations—Lisinopril—dilated cardiomyopathy	0.000859	0.00155	CcSEcCtD
Gabapentin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000855	0.00154	CcSEcCtD
Gabapentin—Cough—Lisinopril—dilated cardiomyopathy	0.000848	0.00153	CcSEcCtD
Gabapentin—Urticaria—Furosemide—dilated cardiomyopathy	0.00084	0.00151	CcSEcCtD
Gabapentin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000836	0.00151	CcSEcCtD
Gabapentin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000836	0.00151	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000832	0.00211	CbGpPWpGaD
Gabapentin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000828	0.00149	CcSEcCtD
Gabapentin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000828	0.00149	CcSEcCtD
Gabapentin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000828	0.00149	CcSEcCtD
Gabapentin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000825	0.00149	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000824	0.00209	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000824	0.00209	CbGpPWpGaD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000822	0.00148	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000819	0.00208	CbGpPWpGaD
Gabapentin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000818	0.00147	CcSEcCtD
Gabapentin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00081	0.00146	CcSEcCtD
Gabapentin—Confusional state—Lisinopril—dilated cardiomyopathy	0.0008	0.00144	CcSEcCtD
Gabapentin—Oedema—Lisinopril—dilated cardiomyopathy	0.000794	0.00143	CcSEcCtD
Gabapentin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000794	0.00143	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000789	0.002	CbGpPWpGaD
Gabapentin—Infection—Lisinopril—dilated cardiomyopathy	0.000788	0.00142	CcSEcCtD
Gabapentin—Shock—Lisinopril—dilated cardiomyopathy	0.000781	0.00141	CcSEcCtD
Gabapentin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000779	0.0014	CcSEcCtD
Gabapentin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000777	0.0014	CcSEcCtD
Gabapentin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000774	0.0014	CcSEcCtD
Gabapentin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000771	0.00139	CcSEcCtD
Gabapentin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000767	0.00138	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000766	0.00194	CbGpPWpGaD
Gabapentin—Asthenia—Furosemide—dilated cardiomyopathy	0.000759	0.00137	CcSEcCtD
Gabapentin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000756	0.00136	CcSEcCtD
Gabapentin—Pruritus—Furosemide—dilated cardiomyopathy	0.000748	0.00135	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000742	0.00188	CbGpPWpGaD
Gabapentin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000742	0.00134	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000736	0.00187	CbGpPWpGaD
Gabapentin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000724	0.0013	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000723	0.0013	CcSEcCtD
Gabapentin—Insomnia—Lisinopril—dilated cardiomyopathy	0.000718	0.00129	CcSEcCtD
Gabapentin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000713	0.00128	CcSEcCtD
Gabapentin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000707	0.00127	CcSEcCtD
Gabapentin—Somnolence—Lisinopril—dilated cardiomyopathy	0.000705	0.00127	CcSEcCtD
Gabapentin—Dizziness—Furosemide—dilated cardiomyopathy	0.000699	0.00126	CcSEcCtD
Gabapentin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000699	0.00126	CcSEcCtD
Gabapentin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00069	0.00124	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000685	0.00123	CcSEcCtD
Gabapentin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000684	0.00123	CcSEcCtD
Gabapentin—Pain—Lisinopril—dilated cardiomyopathy	0.000679	0.00122	CcSEcCtD
Gabapentin—Constipation—Lisinopril—dilated cardiomyopathy	0.000679	0.00122	CcSEcCtD
Gabapentin—Vomiting—Furosemide—dilated cardiomyopathy	0.000672	0.00121	CcSEcCtD
Gabapentin—Rash—Furosemide—dilated cardiomyopathy	0.000667	0.0012	CcSEcCtD
Gabapentin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000666	0.0012	CcSEcCtD
Gabapentin—Headache—Furosemide—dilated cardiomyopathy	0.000663	0.00119	CcSEcCtD
Gabapentin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000654	0.00118	CcSEcCtD
Gabapentin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000649	0.00117	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000634	0.00161	CbGpPWpGaD
Gabapentin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00063	0.00114	CcSEcCtD
Gabapentin—Nausea—Furosemide—dilated cardiomyopathy	0.000628	0.00113	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—RAF1—dilated cardiomyopathy	0.000628	0.00159	CbGpPWpGaD
Gabapentin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000627	0.00113	CcSEcCtD
Gabapentin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000627	0.00113	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000601	0.00152	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000585	0.00148	CbGpPWpGaD
Gabapentin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000585	0.00105	CcSEcCtD
Gabapentin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000569	0.00103	CcSEcCtD
Gabapentin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000561	0.00101	CcSEcCtD
Gabapentin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000543	0.000978	CcSEcCtD
Gabapentin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000525	0.000946	CcSEcCtD
Gabapentin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000505	0.000909	CcSEcCtD
Gabapentin—Rash—Lisinopril—dilated cardiomyopathy	0.0005	0.000902	CcSEcCtD
Gabapentin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0005	0.000901	CcSEcCtD
Gabapentin—Headache—Lisinopril—dilated cardiomyopathy	0.000497	0.000896	CcSEcCtD
Gabapentin—Nausea—Lisinopril—dilated cardiomyopathy	0.000471	0.000849	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000466	0.00118	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000466	0.00118	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000446	0.00113	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000433	0.0011	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GPX1—dilated cardiomyopathy	0.000429	0.00109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000423	0.00107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000423	0.00107	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000419	0.00106	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CD36—dilated cardiomyopathy	0.000418	0.00106	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000393	0.000996	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000381	0.000965	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AGT—dilated cardiomyopathy	0.000376	0.000953	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000358	0.000907	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00034	0.000861	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000325	0.000824	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000308	0.000782	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000281	0.000713	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000264	0.000668	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPX1—dilated cardiomyopathy	0.00026	0.000658	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CD36—dilated cardiomyopathy	0.000253	0.000641	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000252	0.000639	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00025	0.000633	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00025	0.000633	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000239	0.000607	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000232	0.000589	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000229	0.00058	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AGT—dilated cardiomyopathy	0.000228	0.000577	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000225	0.00057	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000192	0.000487	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000182	0.000462	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000159	0.000402	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000157	0.000397	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000141	0.000359	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000135	0.000343	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000109	0.000276	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.38e-05	0.000238	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.43e-05	0.000163	CbGpPWpGaD
